BioSpace News Archive

Projects will help break down barriers to gender equality and support in LGBTQ2 communities

Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Amneal Pharmaceuticals, Inc. (NYSE: AMRX).

Clinical Investigator Dr. Lawrence Bass is a Featured Hot Topics Speaker

Cresco Labs Inc., one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the first quarter ended March 31, 2019 on Wednesday, May 29, 2019 after the market closes.

Brent Zettl, the President and CEO of ZYUS Life Sciences Inc., received the Startup Canada Entrepreneur of the Year Award for the Prairies region in Edmonton, Alberta sponsored by Scotiabank.

National Brain Tumor Society is proud to announce its endorsement of a bipartisan resolution introduced on May 16, 2019, by U.S. Senator Lindsey Graham, with the support of Senators Mitch McConnell, Elizabeth Warren, Kyrsten Sinema, and Martha McSally, to raise public awareness for glioblastoma, a highly aggressive and deadly form of brain cancer that takes thousands of lives every year.

Therachon AG (“Therachon”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare conditions, today announced that it will present interim results from its ongoing Phase II clinical study of apraglutide at Digestive Disease Week® (DDW) in San Diego, CA.

Mylan N.V. (NASDAQ: MYL) yesterday presented at the Bank of America Merrill Lynch Healthcare Conference, where the company announced that it will host an Investor Day on July 31, 2019 in New York City.

Takeda Pharmaceuticals, U.S.A., Inc. (“Takeda”), announced today that the U.S. Food and Drug Administration (FDA) approved extending the indication of GATTEX® (teduglutide) for injection to pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding (parenteral support).1